Latest News

• share
• favorite_border

The webinar will focus on issues related to pregnancy and vasculitis.

• share
• favorite_border

The Vasculitis Foundation (VF) has announced its next webinar, ““Back To School with Vasculitis: Managing your drugs, treatments, social life, doctors’ appointments and oh yes, your classes!”

• share
• favorite_border

The Vasculitis Foundation is pleased to announce it has selected two new research studies on eosinophilic granulomatosis with polyangiitis (EGPA) /Churg Strauss for funding in the amount of $98,000.

• share
• favorite_border

Three new members, Dr. Jeffrey Fishbein, Dr. Peter Grayson, and Dr. Jason M. Springer have been elected to the Vasculitis Foundation Board of Directors.

• share
• favorite_border

The Vasculitis Foundation is pleased to announce the Gary S. Hoffman Vasculitis Foundation Fellowship in honor of Dr. Hoffman.

• share
• favorite_border

Work disability associated with rheumatic diseases accounts for an important part of the costs of these conditions, in addition to direct treatment costs, especially with biological agents. Interest has been growing in studying work disability associated with rheumatoid arthritis, but only a few studies have investigated vasculitis. The purpose of this study is to learn about the impact of vasculitis on employment and income in patients with different systemic vasculitides.

• share
• favorite_border

The Vasculitis Foundation (VF) funded a new one year study led by Renate Kain, MD, from the Medical University of Vienna, Austria. The VF provided the $50,000 award through its Vasculitis Research Program.

• share
• favorite_border

The Vasculitis Foundation (VF) is funding a new, one-year study led by principal investigator, Jonathan Choy, Ph.D., from Simon Fraser University, Burnaby, British Columbia Canada.

• share
• favorite_border

Vasculitis Foundation funds new vasculitis study.

• share
• favorite_border

The Vasculitis Patient-Powered Research Network (www.vpprn.org) has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute (PCORI) as part of the second phase of the National Patient-Centered Clinical Research Network (PCORnet).

• share
• favorite_border

Experts from the Mayo Clinic, Cleveland Clinic, Stanford, PENN, UNC, and the NIH will offer education and networking opportunities for people, families, and friends living with vasculitis, a family of rare autoimmune diseases.